Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection
Authors:
- 11 April 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 162 (2) , 417-423
Abstract
Purpose Magnetic resonance imaging (MRI) is the current standard for preoperative planning of glioblastoma (GBM) surgery. However, recent data on the use of 11 C-methionine positron emission tomography (11[C]-MET PET) suggest its role in providing additional information beyond MRI. The purpose of this study is to establish if there is a correlation between anatomical and metabolic data. Methods We retrieved all GBM cases treated from 2014 to January 2021. Preoperative MRI (Enhancing Nodule -EN-, FLAIR and Total Tumor Volume -TTV-), PET volumes and histological samples obtained from the different tumor regions were evaluated to analyze potential correlations between anatomical, metabolic and pathological data. Results 150 patients underwent surgery for GBM and 49 of these were also studied preoperatively with 11[C]-MET PET; PET volume was evaluated in 47 patients. In 33 patients (70.21%) preoperative 11[C]-MET PET volume > preoperative EN volume and in 11 (23.4%) preoperative 11[C]-MET PET volume > preoperative TTV. We found a significant correlation between preoperative TTVs and PET volumes (p = 0.016) as well as between preoperative EN volumes and PET volumes (p = < 0.001). Histologically, 109 samples were evaluated. ENs samples exhibited the conventional GBM morphology while samples from the FLAIR regions showed white matter tissue, with focal to diffuse tumor cells infiltration and areas of reactive astrogliosis. Conclusion We submit that 11[C]-MET PET volume generally overcome EN. The presence of neoplastic cells confirm these metabolic data. It should be considered in the surgical planning to achieve a Supra Total Resection (SupTR).Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Natural history of de novo high grade glioma: first description of growth parabolaJournal of Neurosurgical Sciences, 2020
- Tumor location and patient age predict biological signatures of high-grade gliomasNeurosurgical Review, 2017
- Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experienceJournal of Neuro-Oncology, 2017
- Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomasNeuro-Oncology, 2016
- The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?Journal of Neurosurgery, 2016
- Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastomaJournal of Neuro-Oncology, 2016
- Portable Intraoperative Computed Tomography Scan in Image-Guided Surgery for Brain High-grade GliomasOperative Neurosurgery, 2016
- Role of Surgical Resection in Low- and High-Grade GliomasCurrent Treatment Options in Neurology, 2014
- Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation StatusJournal of Clinical Oncology, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005